Establishing and maintaining a competitive advantage in the life sciences industry means offering more innovative, patient-centric solutions that are not only safe and efficacious but are also convenient and truly address patients’ needs. Corporate growth and survival demand the ability to adapt to this changing landscape by optimizing an organization’s “innovation engine” without compromising time-to-market. In this webinar, you’ll get key insights into the development of patient-centric innovations.
Join us for this live webinar where we will discuss:
- The new generation of cloud-based digital technologies that have lowered the cost of innovation while increasing reliability and robustness of solutions
- How companies can leverage the Digital Twin concept to optimize the operation and maintenance of assets, systems and manufacturing processes in life sciences
- Advancing biomedical engineering with new technologies designed to advance cardiovascular science through realistic simulation (the Living Heart Project)
Dr. Steve Levine, Sr. Director, Strategic Initiatives – Life Sciences Industry, Dassault Systèmes
Dr. Levine is Sr. Director of Life Science and the Executive Director of the Living Heart Project at Dassault Systèmes. Steve is responsible for leading the DS strategy for digital healthcare, including the 3DEXPERIENCE Twin, which uses advanced AI and VR to create functioning 3D human models. He is also responsible for incubating a startup community within the 3DEXPERIENCE Labs at DS and creating a marketplace of digital healthcare services. Steve holds a Ph.D. in Materials Science from Rutgers University and was elected as a Fellow in the American Institute for Medical and Biological Engineering (AIMBE). Steve has nearly 30 years of experience driving innovation in technology, beginning his career in health tech at the San Diego based startup Biosym that went public as Accelrys in 2004 and acquired by Dassault Systèmes in 2014.
Pierre Frouin, Chief Executive Officer, BioSerenity
Pierre Frouin has a Masters in IT Engineering and an MBA from INSEAD. Pierre did his whole career in the Medical Industry. A third in Asia, a third in Europe and a third in North America. With experience in the pharmaceutical industry and medical device business, Pierre founded BioSerenity in 2014, a company that has received many awards for its medical innovations. BioSerenity employs over 90 people, has a revenue of over 7 million dollars and recently raised 20 million dollars to support its growth. The company develops mobile medical diagnostics and monitoring solutions using smart clothing and an AI assistant.
Who Should Attend?
Senior professionals from Life Sciences organizations, including:
- Chief Operating Officers
- Chief Scientific Officers
- Quality Assurance (QA)
- Quality Control (QC)
- Regulatory Affairs
- Research & Development
- Process Development
What You Will Learn
Learn about lowering the cost of innovation through cloud-based digital technologies, using the Digital Twin concept, and realistic simulation through the Living Heart Project.
The pace of change in the Life Sciences industry is both exciting and extraordinary, resulting in core paradigm shifts in both strategies and processes for key industry stakeholders. Leading Life Sciences organizations understand that in order to meet these challenges they must excel in scientific leadership and innovation for processes throughout their ecosystem to create competitive advantage, and deliver holistic, superior patient and physician-centric experiences.